|
Market Closed -
Nasdaq
04:00:00 2026-09-10 pm EDT
|
5-day change | 1st Jan Change | ||
| 57.43 USD | -1.54% |
|
-2.88% | +31.03% |
| Sep. 09 | Exelixis, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 08:40 AM | |
| Sep. 09 | Adagene Receives Milestone Payment From Exelixis | MT |
| Market Cap | 14.23B 12.24B 11.55B 10.52B 19.66B 1,361B 19.84B 138B 52.93B 690B 53.44B 52.27B 2,192B | P/E 2026 * |
17.7x | P/E 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 13.49B 11.6B 10.94B 9.97B 18.64B 1,289B 18.8B 130B 50.16B 654B 50.64B 49.53B 2,077B | EV / Sales 2026 * |
5.28x | EV / Sales 2027 * | 4.35x |
| Free-Float |
98.15% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| EXEL | Delayed | |
CBOE
| EXEL | Real-time | |
|
Tradegate
| EX9 | Real-time | |
|
Boerse Muenchen
| EX9 | Real-time | |
|
Deutsche Boerse AG
| EX9 | Delayed | |
|
Börse Stuttgart
| EX9 | Delayed | |
|
Berne S.E.
| EX9 | End-of-day quote | |
|
Borsa Italiana
| 1EXEL | End-of-day quote |
Last Transcript : Exelixis, Inc.
| 1 day | -1.54% | ||
| 1 week | -2.88% | ||
| Current month | +5.11% | ||
| 1 month | +8.44% | ||
| 3 months | +9.22% | ||
| 6 months | +39.09% | ||
| Current year | +31.03% |
| 1 week | 56.95 |  | 59.41 |
| 1 month | 49.97 | | 59.72 |
| Current year | 39.71 | | 59.72 |
| 1 year | 33.76 | | 59.72 |
| 3 years | 18.64 | | 59.72 |
| 5 years | 14.87 | | 59.72 |
| 10 years | 10.04 | | 59.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2010-07-21 | |
| Director of Finance/CFO | 58 | 2015-07-14 | |
Dana Aftab
COO | Chief Operating Officer | 63 | 2016-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 2004-01-31 | |
George Poste
BRD | Director/Board Member | 82 | 2004-07-31 |
| Chairman | 77 | 1997-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/10/26 | Sell | Director | -9,812 | 0.0039% | ||
| 6/1/26 | Sell | Director | -9,812 | 0.0039% | ||
| 6/1/26 | Sell | Director | -3,925 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.54% | -2.88% | +52.33% | +159.75% | 14.45B | |
| -0.25% | -1.36% | +44.08% | +102.76% | 68.52B | |
| -1.09% | -6.20% | +30.50% | +76.56% | 62.88B | |
| -1.18% | +0.47% | -12.78% | +384.69% | 28.13B | |
| -2.61% | -6.02% | +28.39% | +8.24% | 25.56B | |
| -1.76% | -6.30% | -4.55% | -19.75% | 24.65B | |
| -2.39% | -5.19% | +17.75% | -20.95% | 19.81B | |
| -1.86% | -2.22% | +202.03% | +353.89% | 17.69B | |
| -1.85% | -4.99% | -5.33% | +495.39% | 14.66B | |
| -3.08% | -0.76% | -3.44% | +1,003.90% | 13.99B | |
| Average | -1.78% | +0.21% | +34.90% | +254.45% | 29.04B | |
| Weighted average by Cap. | -1.40% | -1.11% | +33.57% | +178.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.55B 2.2B 2.07B 1.89B 3.53B 244B 3.56B 24.67B 9.49B 124B 9.59B 9.38B 393B | 2.9B 2.49B 2.35B 2.14B 4.01B 277B 4.04B 28.03B 10.79B 141B 10.89B 10.65B 447B |
| Net income | 821M 706M 666M 607M 1.13B 78.46B 1.14B 7.93B 3.05B 39.8B 3.08B 3.01B 126B | 1.01B 871M 821M 748M 1.4B 96.79B 1.41B 9.78B 3.77B 49.09B 3.8B 3.72B 156B |
| Net Debt | -744M -640M -604M -550M -1.03B -71.18B -1.04B -7.19B -2.77B -36.1B -2.8B -2.73B -115B | -1.62B -1.4B -1.32B -1.2B -2.24B -155B -2.26B -15.68B -6.04B -78.69B -6.09B -5.96B -250B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | $57.43 | -1.54% | 1,789,527 |
| 26-09-09 | $58.33 | +1.14% | 1,770,279 |
| 26-09-08 | $57.67 | -2.27% | 2,538,923 |
| 26-09-04 | $59.01 | -0.20% | 1,580,988 |
| 26-09-03 | $59.13 | +1.03% | 2,141,585 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EXEL Stock
Select your edition
All financial news and data tailored to specific country editions
